Clinical Trial Update: Preventing Depression in Patients With Macular Degeneration [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of depression in patients with macular degeneration has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Major Depressive Disorder

Snippet

Sponsor: Thomas Jefferson University | Conditions: Depression, Macular Degeneration | Phase 3 | Status: COMPLETED